KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Amortizatization of Intangibles (2016 - 2025)

Neogenomics (NEO) has disclosed Amortizatization of Intangibles for 14 consecutive years, with $7.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortizatization of Intangibles fell 75.7% year-over-year to $7.6 million, compared with a TTM value of $31.8 million through Dec 2025, down 22.79%, and an annual FY2025 reading of $31.8 million, down 5.06% over the prior year.
  • Amortizatization of Intangibles was $7.6 million for Q4 2025 at Neogenomics, down from $23.0 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $31.4 million in Q4 2024 and bottomed at -$7.2 million in Q2 2025.
  • Average Amortizatization of Intangibles over 5 years is $7.9 million, with a median of $8.0 million recorded in 2024.
  • The sharpest move saw Amortizatization of Intangibles soared 1214.82% in 2023, then plummeted 1158.53% in 2025.
  • Year by year, Amortizatization of Intangibles stood at $21.3 million in 2021, then plummeted by 96.86% to $668000.0 in 2022, then skyrocketed by 1214.82% to $8.8 million in 2023, then surged by 257.57% to $31.4 million in 2024, then crashed by 75.7% to $7.6 million in 2025.
  • Business Quant data shows Amortizatization of Intangibles for NEO at $7.6 million in Q4 2025, $23.0 million in Q3 2025, and -$7.2 million in Q2 2025.